Christopher Kendall Ph. D.

Christopher Kendall, Ph.D. has a diverse work experience. Christopher started their career in academia at Université de Montréal, where they worked as a Post-Doctoral Fellow from 2004 to 2006. Following this, they joined Wyeth as a Senior Research Scientist I from 2006 to 2010. Christopher then transitioned to Ernst & Young, where they worked as a Manager from 2011 to 2017. Currently, they hold the position of VP of Finance and FP&A at Repare Therapeutics since 2017.

Christopher Kendall, Ph.D. has an extensive education history. Christopher pursued a Bachelor of Science degree in Applied Chemistry (co-op) at the University of Waterloo from 1992 to 1997. Following this, from 1997 to 1999, they attended Queen's University, where they completed a Master of Science degree in Organic Chemistry. Christopher furthered their studies at the University of Pittsburgh from 1999 to 2004, successfully earning a Ph.D. in Organic Chemistry. Returning to McGill University, they obtained a Diploma in Accounting from 2010 to 2012, followed by a Graduate Diploma in Public Accountancy from 2012 to 2013.